Dexcom (DXCM) Share-based Compensation (2010 - 2026)
Dexcom (DXCM) posted quarterly Share-based Compensation of $39.0 million for Q2 2026, down 13.91% year-over-year from $45.3 million in Q2 2025, and down 9.93% quarter-over-quarter from $43.3 million in Q1 2026.
Dexcom (DXCM) Share-based Compensation (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Share-based Compensation for 17 consecutive years, with $39.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Share-based Compensation fell 13.91% year-over-year to $39.0 million; the TTM figure through Jun 2026 stood at $162.4 million (down 2.29% YoY), while the FY2025 annual figure was $159.6 million, down 6.34% from the prior year.
- Share-based Compensation fell to $39.0 million in Q2 2026 per DXCM's latest filing, from $43.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $45.3 million in Q2 2025 and bottomed at $29.1 million in Q1 2022.
- Historically, Share-based Compensation has averaged $38.3 million across 5 years, with a median of $39.0 million in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation climbed 29.28% — and 2025, when it decreased 19.17%.
- Dexcom's Share-based Compensation stood at $34.0 million in 2022, then rose by 8.53% to $36.9 million in 2023, then increased by 17.34% to $43.3 million in 2024, then dropped by 19.17% to $35.0 million in 2025, then increased by 11.43% to $39.0 million in 2026.
- Business Quant data shows DXCM's Share-based Compensation at $39.0 million in Q2 2026, $43.3 million in Q1 2026, and $35.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.25 Bn | 18.84 Bn | 1.54 Bn | 23.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.00 Mn |
| Jun 30, 2026 | 39.00 Mn |
| Mar 31, 2026 | 35.80 Mn |
| Mar 31, 2026 | 35.80 Mn |
| Dec 31, 2025 | 35.00 Mn |
| Dec 31, 2025 | 35.00 Mn |
| Sep 30, 2025 | 45.10 Mn |
| Sep 30, 2025 | 45.10 Mn |
| Jun 30, 2025 | 79.50 Mn |
| Jun 30, 2025 | 79.50 Mn |
| Dec 31, 2024 | 43.30 Mn |
| Dec 31, 2024 | 43.30 Mn |
| Sep 30, 2024 | 43.40 Mn |
| Sep 30, 2024 | 43.40 Mn |
| Jun 30, 2024 | 44.70 Mn |
| Jun 30, 2024 | 44.70 Mn |
| Mar 31, 2024 | 39.00 Mn |
| Mar 31, 2024 | 39.00 Mn |
| Dec 31, 2023 | 36.90 Mn |
| Dec 31, 2023 | 36.90 Mn |